Viemed Healthcare

VMD

Market cap $369M

LAFAYETTE, LA / ACCESS Newswire / March 16, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced it will present and host one-on-one meetings with investors at Sidoti's Small-Cap Virtual Investor Conference, taking place on March 18-19, 2026. The presentation will begin at 1:45 p.m.

Dallas, Texas--(Newsfile Corp. - March 11, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).

Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript

LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that its Board of Directors has authorized a share repurchase program effective through March 2027. Under the share repurchase program, which constitutes a normal course issuer bid under applicable Canadian securities laws, Viemed may purchase up to 1,930,131 common shares of the Company ("the Common Shares") from time to time in accordance with applicable securities laws, representing approximately 5% of the total issued and outstanding Common Shares as of March 4, 2026.

LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months and year ended December 31, 2025, and issued its guidance for the full year ending December 31, 2026. Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD): Net revenues for the quarter ended December 31, 2025 were a company record $76.2 million, an increase of $15.5 million, or 26%, over net revenues reported for the comparable quarter ended December 31, 2024.

LAFAYETTE, LA / ACCESS Newswire / February 24, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Year End 2025 earnings conference call on Thursday, March 5, 2026, at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=hp8iUwVS Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.

Viemed Healthcare is reiterated as a 'Buy' due to robust revenue, earnings, and cash flow growth, alongside an expanding patient base. Q1 and Q2 2025 saw strong organic growth, with Lehan's acquisition quickly accretive and driving further patient count gains. Despite recently trimming FY2025 top-line guidance, VMD's valuation remains compelling with P/E, P/S, and P/B well below 5-year averages.

Dallas, Texas--(Newsfile Corp. - January 6, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners initiates their coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).

Viemed Healthcare, Inc. ( VMD ) Q3 2025 Earnings Call November 6, 2025 11:00 AM EST Company Participants Trae Fitzgerald - Chief Financial Officer Casey Hoyt - CEO & Director Todd Zehnder - COO & Director Conference Call Participants Doug Cooper - Beacon Securities Limited, Research Division Robert Lynch Ilya Zubkov - Freedom Broker, Research Division Presentation Operator Greetings, and welcome to the Viemed Healthcare Third Quarter 2025 Earnings Call. [Operator Instructions] Please note, this conference is being recorded.

LAFAYETTE, LA / ACCESS Newswire / November 5, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced today that it has reported its financial results for the three and nine months ended September 30, 2025. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended September 30, 2025 were $71.9 million, setting a Company record, representing an increase of $13.9 million, or 24.0%, over net revenues reported for the comparable quarter ended September 30, 2024.